Royster & Royster Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 204 W Maple St, Cherokee, IA 51012 Phone: 712-225-5344 Fax: 888-375-5343 |
Pathways Centers For Emotional Well-being, Plc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 215 N 2nd St, Cherokee, IA 51012 Phone: 712-225-2811 |
News Archive
Idera Pharmaceuticals, Inc. today presented data showing that IMO-4200, a dual agonist of Toll-like receptor (TLR) 7 and TLR8, in combination with approved cancer treatments, rituximab or bortezomib, significantly increased antitumor activity in several preclinical lymphoma models. The presentation, entitled "Antitumor Activity of an RNA-Based Agonist of TLR7 and 8 in Preclinical Models of Hematological Malignancies," was made at the 52nd Annual Meeting of the American Society for Hematology in Orlando, Florida by Idera scientists.
Noven Pharmaceuticals, Inc. today announced that it has completed the acquisition of global rights to Daytrana® (methylphenidate transdermal system) from affiliates of Shire plc.
A Flinders University study has highlighted the challenges and shortfalls in support for our nurses who regularly deliver end-of-life care and comforti bereaved family members in often crowded and chaotic hospital emergency departments.
A groundbreaking research collaboration at the University of Virginia School of Medicine that is shedding light on everything from cancer to diabetes to cardiovascular disease has received $12.5 million from the National Institutes of Health.
A UT Dallas professor is studying the differences between the social impairments found in autism and schizophrenia to help develop better treatments for people with both disorders.
› Verified 7 days ago